Stopping Cancer Before It Spreads: The EMT Revolution in Oncology
-
最新报道：Pfizer, Bristol Myers Squibb, and Roche are advancing EMT-focused cancer therapies, with Pfizer's PF-06952229 and BMS-986416 targeting TGF-β to inhibit metastasis. Propanc Biopharma's PRP, a dual-action proenzyme therapy, reverses EMT and eliminates cancer stem cells, showing a 3.4-month survival extension in compassionate use studies. With 90 patents and planned Phase 1 trials by 2026, PRP aims to prevent recurrence and resistance across multiple cancers.
下一篇
Pepe Breaks Out Amid Memecoin Rally: What’s Happening?
- PEPE surged 4.1% in 24 hours and 3.4% weekly, outperforming Bitcoin's modest gains, amid a...
24小时热点
热点专题
407232